Vol. 12. Núm. S2.
Páginas 14-18 (Junio 2005)

Prevención secundaria de la enfermedad cerebrovascular

Opciones

Identifíquese

¿Aún no es suscriptor de la revista?

Comprar el acceso al artículo

Comprando el artículo el pdf del mismo podrá ser descargado

Teléfono para incidencias

De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h

Llamadas desde España 932 415 960
Llamadas desde fuera de España +34 932 415 960
Bibliograf¿a
[1]
Atención hospitalaria organizada (unidad de accidentes cerebrovasculares) para el accidente cerebrovascular. En: Cochrane Library plus en español. Oxford: Update Software; 2001.
[2]
Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003;34:1056-83.
[3]
European Stroke Initiative Recommendations for Stroke Management. Update 2003. Cerebrovasc Dis. 2003;16:311-37.
[4]
Surgery for primary intracerebral hemorrhage: is it safe and effective? A systematic review of case series and randomized trials. Stroke. 1997;28:2126-32.
[5]
Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology. 1998; 50:876-83.
[6]
Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2:81-4.
[7]
Stroke. 1999;30:2033-7.
[8]
Blood pressure and clinical outcomes in the International Stroke Trial. Stroke. 2002; 33:1315-20.
[9]
Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ. 1997;314:1303-6.
[10]
Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke. 1999;30:793-9.
[11]
Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke. 2000;31:410-4.
[12]
Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333:1581-7.
[13]
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet. 1997;349:1569-81.
[14]
Anticoagulants and antiplatelet agents in acute ischemic stroke. Stroke. 2002;33:1934-42.
[15]
Popularion based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ. 2004;328:326-8.
[16]
Very early risk of stroke after a first transient ischemic attack. Stroke. 2003;34:138-40.
[17]
Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284:2901-6.
[18]
Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ. 2004;170:1105-9.
[19]
Life alter stroke. New Zealand guidline for management of stroke. Best practice evidente guideline. November 2003 [citado 10 Jul 2004]. Disponible en: http://www.nzgg.org.nz
[20]
Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 1999;30:1991-4.
[21]
Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet. 1993; 342:1255-62.
[22]
Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a metaanalysis. Ann Intern Med. 1999;131:492-501.
[23]
Effect of endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and to the timing of surgery. Lancet. 2004;363:915-24.
[24]
Guía de actuación clínica en el ataque isquémico transitorio [citado el 10 de agosto 2004]. Disponible en: http://www.sen.es/formacion/ictus/AITGuiadoc.htm
[25]
The Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for the prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
[26]
Stroke. Lancet. 2003;362:1211-24.
[27]
Cigarette smoking and risk of stroke in middle-aged women. N Engl J Med. 1988;318:937-41.
[28]
Smoking cessation and decreased risk of stroke in women. JAMA. 1993;269:232-6.
[29]
Smoking cessation and the risk of stroke in middle-aged men. JAMA. 1995;274:155-60.
[30]
Behavioural counselling in general practice for the promotion of healthy behaviour among adults at increased risk of coronary heart disease: randomised trial. BMJ. 1999;3 19:943-7.
[31]
Post-stroke antihypertensive treatment study: a preliminary result. Clin Med J. 1995; 108:710-7.
[32]
Randomised trial of a perindopril-based bllod-pressure-lowering regimeng among 6.105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-41.
[33]
SPARCL Investigators. Design and baseline characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) study. Cerebrovasc Dis. 2003;16:389-95.
[34]
Effects of cholesterol- lowering on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other highrisk conditions. Lancet. 2004;363:757-67.
[35]
Statins after ischemic stroke and transient ischemic attack. Stroke. 2004;35:1023.
[36]
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360:1623-30.
[37]
Prevention of ischaemic stroke. BMJ. 2000;321:1455-9.
[38]
Comparison of triflusal and aspirin for prevention of vascular events inpatients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial. Stroke. 2003;34:840-8.
[39]
A randomised blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-39.
[40]
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patientes undergoing percutaneus coronary intervention: the PCI-CURE study. Lancet. 2001;358:527-33.
[41]
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): rendomised, double-blid, placebo-controled trial. Lancet. 2004;364:331-7.
[42]
New evidence for stroke prevention. Scientific review. JAMA. 2002;288:1388-95.
[43]
Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography. Ann Intern Med. 2003;139:1018-33.
[44]
Antithrombotic therapy in valvular heart disease. Chest. 2001;119:S207-19.
[45]
American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy. Circulation. 2003;107:1692-711.
[46]
Current and future concepts in stroke prevention, CMAJ. 2004;170:1123-33.
[47]
A comparison of warfarin and aspirin for the prevention of recurrent stroke. N Engl J Med. 2001; 345:1444-51.
[48]
Anticoagulation for preventing stroke in patientes with non-reumatic atrial fibrillation and a history of stroke or transient ischemic attack. Stroke. 2004; 35:1782-3.
[49]
Platelet-active drugs. The relationships among dose, effectiveness, and side effects. Chest. 2001;119:S39-63.
[50]
Antithrombotic therapy in atrial fibrillation. Chest. 2001;119:S194-206.
[51]
Managements of patients with stroke. II: Management of carotid stenosis and carotid endarterectomy. A national clinical guideline. Edinburgh: Sing; 1997.
[52]
Endarterectomía carotídea para la estenosis carotídea sintomática. En: Cochcrane Library plus en español. Oxford: Update Software; 1999.
[53]
Lancet. 2001;357:1729-37.
[54]
Long-term outcome after angioplasty for symptomatic extracranial carotid stenosis in poor surgical candidates. Stroke. 2002;33:2877-80.
[55]
A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med. 2001;345:1243-9.
[56]
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ. 2002;325:1202-6.
[57]
Dietary intake of folate and risk of stroke un US men and women. NHANES I Epidemiologic Follow-Up Strudy. Stroke. 2002:33;1183-8.
[58]
Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke. Myocardial infarction, and death. The Vitamin Intervention for Stroke Prevention (VISP) Randomised Controlled Trial. JAMA. 2004; 291:565-75.
[59]
Folate and the risk of stroke: fortify first and ask questions later? Stroke. 2002;33:1188-9.
[60]
Antithrombotic therapy for atrial fibrillation. BMJ. 2002;325:1022-5.